The 20 Best Pure Red Cell Aplasia Doctors Near Me in San Francisco, CA

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Advanced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.

I encourage my patients to be involved in the decision making process for their health care and health maintenance. An informed patient is an empowered patient! I am absolutely open to complementary medicine if the patient is interested in pursuing this approach in an integrative fashion. I offer compassionate, thoughtful, evidence based medical care and believe strongly that healing and prevention are optimized in the setting of a supportive and long term working relationship with my patients. Dr. Maybury is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Obesity, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension. Dr. Maybury is board certified in Internal Medicine. Dr. Maybury is currently accepting new patients.

Dr. Catherine Smith is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis. Smith's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients. A San Francisco native, Smith earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Essential Thrombocythemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Bone Marrow Aspiration. Dr. Smith is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Smith is currently accepting new patients.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Chung is currently accepting new patients.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Martin is board certified in American Board Of Internal Medicine, Hematology. Dr. Martin is currently accepting new patients.

Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sayre is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Sayre is currently accepting new patients.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wolf is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Medicine, Internal Medicine. Dr. Wolf is currently accepting new patients.

Dr. Karin Gaensler is a specialist in cancers of the blood who has a special interest in gene therapy. She is currently working to develop novel approaches for treating blood disorders caused by a specific gene mutation. Gaensler earned her medical degree from Harvard Medical School. She then went on to complete her residency in internal medicine and a fellowship in hematology and oncology at UCSF. Gaensler has received numerous awards, including a fellowship from the American Cancer Society, a fellowship from the Howard Hughes Medical Institute and a physician-scientist award from the National Institutes of Health. Dr. Gaensler is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Richter Syndrome, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gaensler is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology, American Board Of Internal Medicine/Hematology, Hematology, and American Board Of Internal Medicine, Internal Medicine. Dr. Gaensler is currently accepting new patients.

Lloyd Damon is an Oncologist practicing medicine in San Francisco, California. He has been practicing medicine for over 44 years. Dr. Damon is rated as an Advanced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Fong is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Phosphoglycerate Kinase Deficiency, Glycogen Storage Disease Type 0, Glycogen Storage Disease Type 9, and Phosphoglycerate Mutase Deficiency. Dr. Fong is board certified in Internal Medicine. Dr. Fong is currently accepting new patients.

Dr. Michael Potter is a family doctor who cares for children as well as adults of all ages. In his research, Potter focuses on preventive health and the management of chronic illnesses in primary care settings. He also examines how the design of health care systems influences the care of people in the community. Potter earned his medical degree from Harvard Medical School. He completed his residency in family practice at UCSF and has been a member of the UCSF faculty since 1994. Dr. Potter is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Potter is board certified in American Board Of Internal Medicine, Family Medicine. Dr. Potter is currently accepting new patients.

Neil Dunavin is an Oncologist practicing medicine in San Francisco, California. He has been practicing medicine for over 17 years. Dr. Dunavin is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Aaron Logan is a Hematologist practicing medicine in San Francisco, California. Dr. Logan is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.

Andrew Leavitt is a Hematologist practicing medicine in San Francisco, California. Dr. Leavitt is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Hemophilia A, Von Willebrand Disease (VWD), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Louise Lo is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Lo is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Hereditary Spherocytosis, Thalassemia, Acute Lymphoblastic Leukemia (ALL), and Alpha Thalassemia.

Bertrand Tuan is a Hematologist practicing medicine in San Francisco, California. Dr. Tuan is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Thalassemia, Smoldering Multiple Myeloma, Paroxysmal Nocturnal Hemoglobinuria (PNH), Reticuloendotheliosis, and Bone Marrow Aspiration.

Michael Albert is a primary care provider, practicing in Internal Medicine in San Francisco, California. He has been practicing medicine for over 10 years. Dr. Albert is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Nijmegen Breakage Syndrome, Wiskott-Aldrich Syndrome, Autosomal Dominant Hyper IgE Syndrome, Splenectomy, and Spinal Fusion.

Patricia Cornett is an Oncologist practicing medicine in San Francisco, California. Dr. Cornett is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Shwartzman Phenomenon, Venous Thromboembolism (VTE), Hereditary Pyropoikilocytosis, Hereditary Elliptocytosis, and Bone Marrow Aspiration.

Nina Shah is an Oncologist practicing medicine in San Francisco, California. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Vanessa Kennedy is a Hematologist practicing medicine in San Francisco, California. She has been practicing medicine for over 10 years. Dr. Kennedy is rated as an Experienced provider by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.